Sign in

CIK 0001782223

  • Emerging growth company

Pyxis Oncology, Inc.

Sign in to watch
Ticker
PYXS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831160910
Phone
+1 617-221-9059
Business address
321 HARRISON AVENUE, BOSTON, MA, 02118
Open-market buys, last 90 days
$0
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-04 Civik Thomas CEO & Chairman of the Board Grant or award · Stock Option (Right to Buy) +2,503,050 2,503,050
2026-08-12 Civik Thomas Interim CEO Grant or award · Stock Option (Right to Buy) +250,956 941,087
2026-02-03 Civik Thomas Interim CEO Grant or award · Stock Option (Right to Buy) +690,131 690,131
2025-03-31 Civik Thomas Director Grant or award · Stock Option (Right to Buy) +36,979 $0.98 $36K 36,979
2024-03-26 Civik Thomas Director Grant or award · Stock Option (Right to Buy) +44,024 $3.83 $169K 44,024
2023-03-24 Civik Thomas Director Grant or award +139,355 206,186
2022-03-31 Civik Thomas Director Grant or award +66,831 66,831
2021-11-18 Civik Thomas Director Purchase +15,700 $12.74 $200K 15,700
2021-10-07 Civik Thomas Director Grant or award · Stock Option (Right to buy) +42,191 42,191

Page 1 of 1 · 9 trades